Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Grant

Showing results (221-230 of 386) with videos related to

Pageof 39
Sort By:
Molecular Genetics and Metabolism|December 24, 2014
Targeting novel signaling pathways for resistant acute myeloid leukemiaKathleen M Sakamoto, Steven Grant, Diana Saleiro, et al.
The Journal of Biological Chemistry|August 6, 2011
Disruption of IkappaB kinase (IKK)-mediated RelA serine 536 phosphorylation sensitizes human multiple myeloma cells to histone deacetylase (HDAC) inhibitorsYun Dai, Shuang Chen, Li Wang, et al.
Molecular Cancer Therapeutics|July 14, 2011
Carfilzomib interacts synergistically with histone deacetylase inhibitors in mantle cell lymphoma cells in vitro and in vivoGirija Dasmahapatra, Dmitry Lembersky, Minkyeong P Son, et al.
Blood|July 2, 2002
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic diseaseRobert J McKallip, Catherine Lombard, Michael Fisher, et al.
Cancer Biology & Therapy|February 23, 2012
OSU-03012 suppresses GRP78/BiP expression that causes PERK-dependent increases in tumor cell killingLaurence Booth, Sophie C Cazanave, Hossein A Hamed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Synergistic interactions between DMAG and mitogen-activated protein kinase kinase 1/2 inhibitors in Bcr/abl+ leukemia cells sensitive and resistant to imatinib mesylateTri K Nguyen, Mohamed Rahmani, Ning Gao, et al.
British Journal of Cancer|December 15, 2017
Flavopiridol enhances ABT-199 sensitivity in unfavourable-risk multiple myeloma cells in vitro and in vivoLiang Zhou, Yu Zhang, Deepak Sampath, et al.
Cancer Biology & Therapy|November 15, 2002
Inhibitors of MEK1/2 interact with UCN-01 to induce apoptosis and reduce colony formation in mammary and prostate carcinoma cellsRobert McKinstry, Liang Qiao, Adly Yacoub, et al.
Molecular Pharmacology|December 31, 2004
Cotreatment with suberanoylanilide hydroxamic acid and 17-allylamino 17-demethoxygeldanamycin synergistically induces apoptosis in Bcr-Abl+ Cells sensitive and resistant to STI571 (imatinib mesylate) in association with down-regulation of Bcr-Abl, abrogation of signal transducer and activator of transcription 5 activity, and Bax conformational changeMohamed Rahmani, Erin Reese, Yun Dai, et al.
Cancer Biology & Therapy|March 22, 2014
PDE5 inhibitors enhance the lethality of standard of care chemotherapy in pediatric CNS tumor cellsJane L Roberts, Laurence Booth, Adam Conley, et al.
Pageof 39

Showing results (221-230 of 386) with videos related to

Sort By:
Pageof 39
Molecular Genetics and Metabolism|December 24, 2014
Targeting novel signaling pathways for resistant acute myeloid leukemiaKathleen M Sakamoto, Steven Grant, Diana Saleiro, et al.
The Journal of Biological Chemistry|August 6, 2011
Disruption of IkappaB kinase (IKK)-mediated RelA serine 536 phosphorylation sensitizes human multiple myeloma cells to histone deacetylase (HDAC) inhibitorsYun Dai, Shuang Chen, Li Wang, et al.
Molecular Cancer Therapeutics|July 14, 2011
Carfilzomib interacts synergistically with histone deacetylase inhibitors in mantle cell lymphoma cells in vitro and in vivoGirija Dasmahapatra, Dmitry Lembersky, Minkyeong P Son, et al.
Blood|July 2, 2002
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic diseaseRobert J McKallip, Catherine Lombard, Michael Fisher, et al.
Cancer Biology & Therapy|February 23, 2012
OSU-03012 suppresses GRP78/BiP expression that causes PERK-dependent increases in tumor cell killingLaurence Booth, Sophie C Cazanave, Hossein A Hamed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Synergistic interactions between DMAG and mitogen-activated protein kinase kinase 1/2 inhibitors in Bcr/abl+ leukemia cells sensitive and resistant to imatinib mesylateTri K Nguyen, Mohamed Rahmani, Ning Gao, et al.
British Journal of Cancer|December 15, 2017
Flavopiridol enhances ABT-199 sensitivity in unfavourable-risk multiple myeloma cells in vitro and in vivoLiang Zhou, Yu Zhang, Deepak Sampath, et al.
Cancer Biology & Therapy|November 15, 2002
Inhibitors of MEK1/2 interact with UCN-01 to induce apoptosis and reduce colony formation in mammary and prostate carcinoma cellsRobert McKinstry, Liang Qiao, Adly Yacoub, et al.
Molecular Pharmacology|December 31, 2004
Cotreatment with suberanoylanilide hydroxamic acid and 17-allylamino 17-demethoxygeldanamycin synergistically induces apoptosis in Bcr-Abl+ Cells sensitive and resistant to STI571 (imatinib mesylate) in association with down-regulation of Bcr-Abl, abrogation of signal transducer and activator of transcription 5 activity, and Bax conformational changeMohamed Rahmani, Erin Reese, Yun Dai, et al.
Cancer Biology & Therapy|March 22, 2014
PDE5 inhibitors enhance the lethality of standard of care chemotherapy in pediatric CNS tumor cellsJane L Roberts, Laurence Booth, Adam Conley, et al.
Pageof 39